rec. | Subject | Hit Length | Description | Align.Len | E value | Bit score | % ident. | % pos. | GO associations |
61 | P26362 | 1492 | CFTR_SQUAC Cystic fibrosis transmembrane cond... | 154 | 8 | 33.9 | 22 | 42 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 62 | Q7FB56 | 1053 | AB15C_ARATH Putative ABC transporter C family... | 286 | 0.009 | 43.5 | 24 | 41 | GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0008559; F:xenobiotic-transporting ATPase activity; IEA:EC. | | | | | | | | | | | 63 | Q8LGU1 | 1464 | AB8C_ARATH ABC transporter C family member 8 ... | 91 | 1.3 | 36.6 | 21 | 49 | GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.::GO:0000325; C:plant-type vacuole; IDA:TAIR.::GO:0005774; C:vacuolar membrane; IDA:TAIR. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0008559; F:xenobiotic-transporting ATPase activity; IEA:EC. | | | | | | | | | | | 64 | Q9LYS2 | 1453 | AB10C_ARATH ABC transporter C family member 1... | 211 | 0.001 | 46.6 | 25 | 45 | GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.::GO:0005774; C:vacuolar membrane; IDA:TAIR. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0008559; F:xenobiotic-transporting ATPase activity; IEA:EC. | | | | | | | | | | | 65 | Q2QL74 | 1482 | CFTR_DIDMA Cystic fibrosis transmembrane cond... | 202 | 0.031 | 42 | 28 | 48 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 66 | Q9R1S7 | 1498 | MRP6_MOUSE Multidrug resistance-associated pr... | 95 | 0.35 | 38.5 | 25 | 51 | GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro. | | | | | | | | | | | 67 | Q9QYM0 | 1436 | MRP5_RAT Multidrug resistance-associated prot... | 114 | 0.005 | 44.7 | 27 | 50 | GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.::GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro. | | | | | | | | | | GO:0032868; P:response to insulin stimulus; IEP:RGD.::GO:0032496; P:response to lipopolysaccharide; IEP:RGD. | 68 | Q9R1X5 | 1436 | MRP5_MOUSE Multidrug resistance-associated pr... | 114 | 0.005 | 44.3 | 27 | 50 | GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro. | | | | | | | | | | | 69 | Q8T6H3 | 1351 | ABCC6_DICDI ABC transporter C family member 6... | 77 | 0.0001 | 49.7 | 32 | 55 | GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; ISS:dictyBase. | | | | | | | | | | | 70 | Q00PJ2 | 1483 | CFTR_ATEAB Cystic fibrosis transmembrane cond... | 208 | 0.03 | 42 | 26 | 44 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 71 | Q108U0 | 1482 | CFTR_LOXAF Cystic fibrosis transmembrane cond... | 208 | 2.9 | 35.4 | 25 | 42 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 72 | Q09YH0 | 1481 | CFTR_SAIBB Cystic fibrosis transmembrane cond... | 208 | 3.1 | 35.4 | 24 | 42 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0005769; C:early endosome; ISS:UniProtKB. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 73 | Q07DX5 | 1480 | CFTR_NOMLE Cystic fibrosis transmembrane cond... | 88 | 1.2 | 36.6 | 25 | 53 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 74 | Q5D1Z7 | 1478 | CFTR_TRIVU Cystic fibrosis transmembrane cond... | 203 | 0.13 | 39.7 | 28 | 47 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0005769; C:early endosome; ISS:UniProtKB. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 75 | Q2IBB3 | 1482 | CFTR_RHIFE Cystic fibrosis transmembrane cond... | 90 | 2.7 | 35.4 | 23 | 53 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0005769; C:early endosome; ISS:UniProtKB. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 76 | Q2QLB4 | 1480 | CFTR_CALMO Cystic fibrosis transmembrane cond... | 208 | 2.8 | 35.4 | 24 | 42 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 77 | Q07DV2 | 1481 | CFTR_AOTNA Cystic fibrosis transmembrane cond... | 208 | 2.8 | 35.4 | 24 | 42 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 78 | Q2IBE4 | 1480 | CFTR_PONAB Cystic fibrosis transmembrane cond... | 90 | 0.87 | 37 | 24 | 53 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0005769; C:early endosome; ISS:UniProtKB. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 79 | Q2IBF6 | 1480 | CFTR_GORGO Cystic fibrosis transmembrane cond... | 88 | 1.2 | 36.6 | 25 | 53 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 80 | Q07DW5 | 1481 | CFTR_MUNRE Cystic fibrosis transmembrane cond... | 105 | 1 | 37 | 28 | 48 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 81 | O88269 | 1502 | MRP6_RAT Multidrug resistance-associated prot... | 95 | 0.66 | 37.7 | 24 | 53 | GO:0016324; C:apical plasma membrane; IDA:RGD.::GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.::GO:0016328; C:lateral plasma membrane; IDA:RGD.::GO:0005624; C:membrane fraction; IDA:RGD. | | | | | | | | | | GO:0005524; F:ATP binding; IDA:RGD.::GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro. | | | | | | | | | | | 82 | Q2QLA3 | 1481 | CFTR_HORSE Cystic fibrosis transmembrane cond... | 103 | 1.6 | 36.2 | 24 | 52 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 83 | P13569 | 1480 | CFTR_HUMAN Cystic fibrosis transmembrane cond... | 88 | 1.1 | 37 | 25 | 53 | GO:0016324; C:apical plasma membrane; IDA:UniProtKB.::GO:0016323; C:basolateral plasma membrane; NAS:UniProtKB.::GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; TAS:ProtInc.::GO:0005224; F:ATP-binding and phosphorylation-dependent chloride channel activity; TAS:ProtInc.::GO:0005260; F:channel-conductance-controlling ATPase activity; NAS:UniProtKB.::GO:0019899; F:enzyme binding; IPI:UniProtKB.::GO:0030165; F:PDZ domain binding; IDA:UniProtKB. | | | | | | | | | | GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc. | 84 | Q2QLE5 | 1480 | CFTR_PANTR Cystic fibrosis transmembrane cond... | 88 | 0.4 | 38.1 | 26 | 55 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 85 | Q09YJ4 | 1481 | CFTR_MUNMU Cystic fibrosis transmembrane cond... | 105 | 1 | 37 | 28 | 48 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 86 | Q5U820 | 1483 | CFTR_CANFA Cystic fibrosis transmembrane cond... | 218 | 0.0003 | 48.5 | 28 | 44 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 87 | Q00554 | 1481 | CFTR_RABIT Cystic fibrosis transmembrane cond... | 88 | 2.4 | 35.8 | 24 | 53 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 88 | Q07DY5 | 1481 | CFTR_COLGU Cystic fibrosis transmembrane cond... | 88 | 1.2 | 36.6 | 25 | 53 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 89 | Q2QL83 | 1481 | CFTR_MICMU Cystic fibrosis transmembrane cond... | 208 | 0.2 | 39.3 | 25 | 43 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 90 | Q09YK5 | 1480 | CFTR_ATEGE Cystic fibrosis transmembrane cond... | 208 | 2.9 | 35.4 | 24 | 42 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | | 91 | Q6PQZ2 | 1482 | CFTR_PIG Cystic fibrosis transmembrane conduc... | 105 | 0.77 | 37.4 | 29 | 47 | GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.::GO:0005769; C:early endosome; ISS:UniProtKB. | | | | | | | | | | GO:0005524; F:ATP binding; IEA:UniProtKB-KW.::GO:0005260; F:channel-conductance-controlling ATPase activity; IEA:EC. | | | | | | | | | | |